NYRADA INC.

5.26%

20.0¢

Market Cap $42.18M

Healthcare Biotechnology

Nyrada Inc is an Australia-based drug development company. The Company focuses on... Nyrada Inc is an Australia-based drug development company. The Company focuses on development of small molecule drugs pertaining to the underlying pathological processes involved in cardiovascular, neurodegenerative and chronic inflammatory diseases. Its drug development programs include a proprotein convertase subtilisin/kexin type nine (PCSK9) inhibitor for the treatment of high blood low-density lipoprotein (LDL)-cholesterol levels in patients poorly responsive to or unable to take statin drugs. It develops a neuroprotectant drug to reduce the impact of long-term disability in patients with ischaemic stroke and traumatic brain injury. The Company also develops a drug to treat pain associated with peripheral nerve damage and autoimmune diseases such as psoriasis.More

RCE'S BREAKTHROUGH

Recce Pharmaceuticals (ASX:RCE) accelerates commercialisation with positive Phase II results.

Latest Threads

Tag

Subject

NYR

Ann: Significant Neuroprotection in Traumatic Brain Injury Study

14/06/25

6.6K

14/06/25

Last post Bendunstan

6.6K

NYR

Ann: Notice of Change of Interests of Substantial Holder - M Azzi

13/06/25

9.8K

13/06/25

Last post Bendunstan

9.8K

NYR

Ann: Change of Director's Interest Notice - RW

13/06/25

154

13/06/25

Last post

ASX News

154

NYR

Ann: Change of Director's Interest Notice - MF

13/06/25

132

13/06/25

Last post

ASX News

132

NYR

Ann: Change of Director's Interest Notice - CC

13/06/25

130

13/06/25

Last post

ASX News

130

NYR

Ann: Change of Director's Interest Notice - JM

13/06/25

120

13/06/25

Last post

ASX News

120

NYR

Ann: Notification of cessation of securities - NYR

13/06/25

161

13/06/25

Last post

ASX News

161

NYR

Ann: Notice of Change of Interests of Substantial Holder - M Azzi

12/06/25

284

12/06/25

Last post

ASX News

284

See All Discussions

Timeline

Change of Director's Interest Notice - RW
13 Jun 09:20	Share

Change of Director's Interest Notice - MF
13 Jun 09:19	Share

Change of Director's Interest Notice - CC
13 Jun 09:18	Share

Change of Director's Interest Notice - JM
13 Jun 09:18	Share

Notification of cessation of securities - NYR
13 Jun 09:09	Share

Notice of Change of Interests of Substantial Holder - M Azzi
12 Jun 08:31	Share

Notice of Change of Interests of Substantial Holder - M Azzi
05 Jun 11:32	Share

Phase I Clinical Trial Protocol Amendment
04 Jun 10:49	Share

Notice of Change of Interests of Substantial Holder - M Azzi
03 Jun 08:25	Share

Notice of Change of Interests of Substantial Holder - M Azzi
28 May 18:08	Share

Notice of Change of Interests of Substantial Holder - M Azzi
26 May 17:00	Share

Lead Drug Candidate Renamed to Xolatryp
23 May 08:57	Share

Notice of Change of Interests of Substantial Holder - M Azzi
21 May 16:24	Share

Phase I Clinical Trial Dosing Update No 3
21 May 09:48	Share

Change of Director's Interest Notice - JM
21 May 09:06	Share

Change of Director's Interest Notice - MF
21 May 09:06	Share

Change of Director's Interest Notice - RW
21 May 08:59	Share

Change of Director's Interest Notice - CC
21 May 08:55	Share

Notice of Ceasing to be a Substantial Holder - NOX
21 May 08:21	Share

Notice of Change of Interests of Substantial Holder from NOX
20 May 09:29	Share

Corporate Update
20 May 09:20	Share

NOX: New funds from Nyrada share sales
20 May 08:48	Share

Notification regarding unquoted securities - NYR
15 May 10:37	Share

Cleansing Statement
15 May 10:35	Share

Application for quotation of securities - NYR
15 May 10:32	Share

NYR-BI03 Extends Cardioprotection to Arrhythmia Control
08 May 08:56	Share

Phase I Clinical Trial Dosing Update No 2
02 May 08:48	Share

Results of Meeting
17 Apr 10:42	Share

Quarterly Activities Report and Appendix 4C
15 Apr 08:23	Share

Notice of Initial Substantial Holder - M Azzi
09 Apr 16:17	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 20.0¢		Change 0.010(5.26%)		Mkt cap ! $42.18M

Open	High	Low	Value	Volume
19.0¢	20.5¢	19.0¢	$248.3K	1.256M

Buyers (Bids)

No.	Vol.	Price($)
1	31147	20.0¢

Sellers (Offers)

Price($)	Vol.	No.
20.5¢	103141	3

View Market Depth

No.	Vol.	Price($)
1	31147	0.200
1	15000	0.195
6	233168	0.190
3	170000	0.185
4	53557	0.180

Price($)	Vol.	No.
0.205	103141	3
0.210	233351	5
0.215	190902	3
0.220	59557	3
0.225	132694	4

Last trade - 16.10pm 13/06/2025 (20 minute delay)

NYR (ASX) Chart

NYRADA INC.

Latest Threads

Timeline

Featured News

Latest Articles

Nyrada pushes through to third cohort in Phase 1 trial for NYR-BI03

Nyrada Inc has been given the go-ahead to a third cohort in its Phase 1 clinical trial into its drug for neuroprotection and cardioprotection

Study finds Nyrada's lead drug can prevent secondary brain injury

Nyrada Inc has reported strong results from a collaborative study it has been engaged in regarding its lead candidate NYR-BI03

Nyrada doses first cohort in trial to assess neuroprotective, cardioprotective drug

Nyrada Inc has dosed the first cohort of patients in its Phase I first-in-human trial to assess the safety and tolerability of NYR-BI03

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News